Alert SGLT2 Inhibitor Diabetes Drugs May Cause Ketoacidosis: FDA Reports of ketoacidosis requiring hospitalization in patients with type 2 diabetes taking sodium-glucose cotransporter-2 inhibitors ...
Consistent adherence to sodium-glucose cotransporter 2 (SGLT2) inhibitors in individuals with type 2 diabetes reduces the risk of hospitalization, supporting targeted interventions to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results